Synlogic (SYBX) Stock: Buy, Sell, or Hold?
$0.56
-0.56 (-50.00%)
βΌ
5d:
-50.44%
30d:
-49.09%
90d:
-67.06%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
42/100
Position
FAIR
Wall Street Target
$1.00
+78.6% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.56 / $1.27
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
βΈοΈ WAIT FOR STABILIZATION: SYBX is down 50.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When SYBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SYBX is currently trading at $0.56, which is considered fair based on recent price action.
Technical Outlook: Technically, SYBX is in a downtrend. The price is currently testing key support at $0.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 50.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+78.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SYBX is in a downtrend. The price is currently testing key support at $0.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 50.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+78.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
42/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$0.56
Resistance Level
$1.27
Current Trend
Downtrend
Technical data as of
Jan 20, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-50.0%)
- BULLISH: Trading 78.6% below Wall St target ($1.00)
- WARNING: Composite score 42/100 in the bottom quintile β this cohort historically lags the market
Fundamental Context
Wall Street Target
$1.00
(+78.6%)
Revenue Growth (YoY)
-100.0%
Share SYBX Analysis
Share this live SYBX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 13, 2026 5:53 AM ET
Data refreshes hourly during market hours. Next update: 6:53 AM
Data refreshes hourly during market hours. Next update: 6:53 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYBX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
ABVX
Abivax SA American Depos⦠|
STRONG BUY
12 analysts |
$164 | 64 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SYBX Research Pages